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The exquisite ability of the liver to regenerate is finite. Identification of mechanisms that 
limit regeneration after massive injury holds the key to expanding the limits of liver 
transplantation and salvaging livers and hosts overwhelmed by carcinoma and toxic insults. 
Receptor for advanced glycation endproducts (RAGE) is up-regulated in liver remnants 
selectively after massive (85%) versus partial (70%) hepatectomy, principally in 
mononuclear phagocyte-derived dendritic cells (MPDDCs). Blockade of RAGE, using 
pharmacological antagonists or transgenic mice in which a signaling-deficient RAGE mutant 
is expressed in cells of mononuclear phagocyte lineage, significantly increases survival after 
massive liver resection. In the first hours after massive resection, remnants retrieved from 
RAGE-blocked mice displayed increased activated NF-
 
 
 
B, principally in hepatocytes, and 
enhanced expression of regeneration-promoting cytokines, TNF-
 
 
 
 and IL-6, and the 
antiinflammatory cytokine, IL-10. Hepatocyte proliferation was increased by RAGE 
blockade, in parallel with significantly reduced apoptosis. These data highlight central roles 
for RAGE and MPDDCs in modulation of cell death–promoting mechanisms in massive 
hepatectomy and suggest that RAGE blockade is a novel strategy to promote regeneration in 
the massively injured liver.
 
The explosive growth of liver surgery and
transplantation as a therapeutic modality over
the last two decades mandates the develop-
ment of novel protective strategies to optimize
outcomes. The ability of the liver to regenerate
upon extensive resection or toxic insult, and to
restore its mass to homeostasis by programmed
regeneration or limited activation of apoptotic
pathways, belies an emerging challenge in the
management of liver disease (1, 2). Despite
widespread interest in the biology of liver re-
generation, the clinically relevant limits of the
ability of the liver to regenerate are not well
understood, and there has been little progress
in the development of therapy to enhance re-
generation and optimize survival when the
liver is excessively small.
Our group has had a long-standing interest
in the use of subtotal hepatectomy as a highly
relevant preclinical model with which to
probe the limits of regeneration in vivo and to
dissect underlying mechanisms and test poten-
tial therapeutic modalities (3). In rodent models,
70% hepatectomy is well tolerated and regen-
eration is permitted to nearly full recovery in
all animals. However, beyond 70% resection,
progressive increments in the extent of re-
sected liver evoke a step-wise acceleration of
morbidity and mortality (3). These observations
established that the state of being “too small” is
inherently toxic to the liver. Therefore, pro-
tective strategies might modify the extent of
tolerable resection.
The development of partial liver transplan-
tation from living human donors made it essen-
tial to determine prospectively the lower limits
of graft size compatible with a successful out-
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come (4, 5). Clinically, this is manifested by the develop-
ment of a cholestatic syndrome of hepatic injury in recipi-
ents of “small for size” livers. The state of the excessively
small liver is highly correlated with mortality in clinical and
experimental settings (3, 5). Although the direct cause of
death in liver failure remains elusive, it is nevertheless estab-
lished that damage to the small liver occurs in an environ-
ment characterized by up-regulation of proinflammatory
pathways; the host experiences failure of restoration of liver
function as well as local and systemic inflammatory injury
(3–5). Thus, dissection of the molecular mechanisms that
thwart the small liver’s attempts to restore homeostatic mass
and function represents a critical step in exploiting the re-
generative capacity of the organ. We hypothesized that in-
flammatory mediators routinely cleared and detoxified by
the liver rapidly overwhelm the hepatic remnant after mas-
sive resection, thereby diverting pathways normally signaled
to restore liver mass and function to those leading to
cell death. Alternatively, the liver remnant, suddenly over-
whelmed by the increased metabolic burden, faces intense
metabolic stress, which might indirectly initiate inflamma-
tory mechanisms.
As the receptor for advanced glycation endproducts
(RAGE) has been linked to escalation of cellular stress subse-
quent to engagement by its ligands (6–8), we tested the
premise that RAGE mediates injurious stress responses in
massive liver resection and initiates events that critically cur-
tail the limits of regeneration.
 
RESULTS
Blockade of RAGE improves survival after 
massive hepatectomy
 
To define the limits of liver regeneration, we used a murine
model of incremental liver injury, partial and well-tolerated
hepatectomy (70% resection; references 9, 10), and established
a model of massive hepatectomy (85% resection). Sham-
treated animals underwent anesthesia and laparotomy, without
liver resection. C57BL/6 mice subjected to 70% hepatectomy
displayed an 
 
 
 
90% probability of survival at 7 d (Fig. 1 A). In
contrast, mice subjected to 85% hepatectomy displayed signif-
icantly reduced probability of survival, 
 
 
 
30% of the animals
were alive by day 7; P 
 
  
 
0.0035 versus 70% resection (Fig. 1
A). These findings demonstrated that beyond resection of 70%
of the liver, mechanisms are engaged that significantly increase
mortality. To explore the potential role of RAGE in massive
(85%) hepatectomy, we first assessed levels of the receptor. An
 
 
 
3.2-fold increase in RAGE transcripts by quantitative PCR
was observed in the hepatic remnant 8 h after massive (85%)
Figure 1. Up-regulation of RAGE in hepatic remnants after massive 
(85%) hepatectomy: cellular localization and impact of ligand/
RAGE blockade. Male C57BL/6 mice were subjected to partial (70%) or 
massive (85%) hepatectomy or sham surgery. Mice subjected to 85% re-
section were treated with murine sRAGE, 100  g per day, or vehicle, PBS 
daily until death. (A) Kaplan-Meier Product Limit Estimate. The times of 
death were recorded for mice undergoing hepatectomy, and survival was 
plotted. (B) Quantitative PCR. Quantitative PCR was performed on liver 
remnants retrieved from mice undergoing sham, 70% or 85% liver resec-
tion, or 85% resection in the presence of sRAGE. After normalization to 
internal controls, levels of murine RAGE transcripts in sham-treated mice 
livers were arbitrarily defined as “1.” In this experiment, n   5 mice per 
group. *, P   0.05 versus 70% hepatectomy. **, P   0.05 versus PBS treat-
ment/85% hepatectomy. (C–F) Immunofluorescence microscopy. 
Immunofluorescence for detection of RAGE antigen was performed in sec-
tions prepared 8 h after sham surgery (C) or massive resection (D, 85%). In 
tissues prepared from remnants after massive resection, double immuno-
fluorescence staining was performed with anti-RAGE IgG (green) and 
an anti-CD68 IgG (E, red), or with anti-RAGE IgG (green) and anti-CD11c 
IgG (F, red) as described before. Single and merged images are shown. 
(C, E, and F) Bars, 50  m. (G) Kaplan-Meier Product Limit Estimate. Male 
C57BL/6 mice were subjected to massive hepatic resection and treated 
with the indicated F(ab )2 fragments of rabbit anti-RAGE, anti-S100/
calgranulin, antiamphoterin, or nonimmune IgG. The times of death were 
recorded for mice undergoing hepatectomy, and survival was plotted. 
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hepatectomy versus 70% hepatectomy or sham procedure;
P 
 
  
 
0.05 (Fig. 1 B). Importantly, RAGE transcripts in the
remnant did not differ between sham-treated mice and those
animals subjected to 70% hepatectomy, thereby suggesting that
perturbation triggered by partial (70%) resection did not trig-
ger up-regulation of this receptor. Immunohistochemistry re-
vealed that remnant tissue expressed increased RAGE epitopes
compared with sham-treated livers at 8 h after massive hepatec-
tomy (Fig. 1, C and D). RAGE expression localized to cells
expressing both CD68 and Cd11c, thereby indicating that
RAGE was principally expressed in dendritic cells, likely
mononuclear phagocyte (MP)-derived DCs (MPDDCs), in
the injured remnant (Fig. 1, E and F). Based on the merged
images in Fig. 1 (E and F), RAGE antigen was not detected to
appreciable degrees in CD68
 
 
 
/CD11c
 
 
 
 cells, thereby sug-
gesting that RAGE was not significantly expressed in Kupffer
cells. Furthermore, RAGE-expressing cells did not express
 
 
 
-smooth muscle actin, thereby indicating that they were not
stellate or smooth muscle cells (unpublished data). In addition,
there was no evidence of colocalization with anti-CD31 IgG,
indicating that RAGE-expressing cells were not endothelial
cells (unpublished data).
To test the concept that engagement of RAGE mediated
deleterious stress responses after massive hepatectomy, we
used several means to block the receptor. First, we adminis-
tered murine soluble RAGE (sRAGE), the extracellular
ligand binding domain of RAGE that serves as a decoy,
thereby suppressing ligand-induced stimulation of cell sur-
face receptor (8, 11). Mice were treated with murine
sRAGE (100 
 
 
 
g per day by intraperitoneal route, beginning
1 d before massive hepatectomy and then daily until sacrifice
or death), or with equal volumes of vehicle, PBS. Kaplan
Meier product limit estimate studies revealed that compared
with mice undergoing 85% hepatectomy receiving PBS, in
whom an 
 
 
 
30% probability of survival was observed at 7 d,
mice receiving sRAGE displayed significantly increased sur-
vival, 
 
 
 
90%; P 
 
  
 
0.0001 (Fig. 1 A). The probability of sur-
vival in sRAGE-treated mice undergoing 85% hepatectomy
was not significantly different than that observed in mice un-
dergoing less extensive resection (70%); P 
 
  
 
0.05 (Fig. 1 A).
In addition to treatment with sRAGE, we administered
blocking F(ab
 
 
 
)
 
2
 
 fragments of either RAGE or its ligands to
wild-type mice undergoing massive resection. Administration
of blocking F(ab
 
 
 
)
 
2
 
 fragments prepared from anti-RAGE IgG
Figure 2. Administration of sRAGE improves survival and enhances 
regeneration after massive hepatectomy. Male C57BL/6 mice were 
subjected to 85% hepatectomy in the presence of the indicated once daily 
dose of sRAGE or vehicle, PBS. (A) Kaplan-Meier Product Limit Estimate. 
The times of death were recorded for mice undergoing hepatectomy in the 
presence of sRAGE versus vehicle, and survival was plotted. Survival 
curves for sRAGE, 100  g/d- and PBS-treated mice, reflect the same ani-
mals as in Fig. 1 A. (B–D) Indices of injury and regeneration. At the indi-
cated times, plasma or hepatic remnant was retrieved and analyzed for 
ALT (B) and Prothrombin Time (C). (D) Liver weight/body weight ratios are 
shown. (B and C) n   3–8 mice per condition. (D) n   10 (PBS) or n   27 
(sRAGE) mice per condition. (B–D) *, P   0.05. (E and F) Histology. Hepatic 
remnants were retrieved and grading was performed based on the per-
centage of necrosis as described before; mean   standard error is shown. 
(E) n   5 mice per condition. *, P   0.05. (F) Representative sections from 
PBS- and sRAGE-treated mice at 24 h are illustrated. Bar, 80  m (inset) 
160  m. (G) Immunoprecipitation. 16 h after 85% hepatectomy, plasma 
from sRAGE- or PBS-treated mice was retrieved and subjected to immu-
noprecipitation using rabbit anti-RAGE IgG. Immunoprecipitated material 
was subjected to blotting using anti-S100/calgranulin IgG. Plasma was 
pooled from n   3 sRAGE- or n   3 PBS-treated plasma for immunopre-
cipitation studies. 
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significantly increased survival of mice undergoing massive
hepatectomy compared with animals treated with nonim-
mune F(ab
 
 
 
)
 
2
 
 fragment; P 
 
  
 
0.04 (Fig. 1 G). These findings
underscored the key role of the cell surface receptor RAGE
in mediating enhanced injury after massive resection. Fur-
thermore, supportive of a key role of RAGE’s proinflamma-
tory ligands, S100/calgranulin and amphoterin, in mediating
liver injury upon massive hepatectomy, administration of
blocking F(ab
 
 
 
)
 
2
 
 fragments prepared from anti-S100/calgran-
ulin or antiamphoterin IgG resulted in significantly increased
probability of survival compared with mice receiving nonim-
mune F(ab
 
 
 
)
 
2
 
 fragments; P 
 
  
 
0.04 (Fig. 1 G). Consistent with
the concept that one consequence of ligand–RAGE engage-
ment is up-regulation of RAGE itself; compared with PBS-
treated mice, remnants retrieved from sRAGE-treated ani-
mals displayed decreased transcripts for RAGE (P 
 
  
 
0.05),
which were not different than those observed in sham-treated
or 70% hepatectomized mice (Fig. 1 B).
The effects of sRAGE were dose dependent; although
mice undergoing 85% hepatectomy in the presence of
sRAGE, 100 
 
 
 
g per day, displayed significantly increased
survival compared with mice receiving PBS (P 
 
  
 
0.0001),
mice receiving sRAGE at 50, 10, or 2 
 
 
 
g per day did not dis-
play significantly improved survival compared with vehicle
treatment (Fig. 2 A). Therefore, in further studies to delineate
the mechanisms by which RAGE blockade enhanced sur-
vival after massive hepatectomy, sRAGE was administered to
the mice at 100 
 
 
 
g/d. Importantly, when we extended these
experiments to 14 d, we found no further mortality in either
sRAGE- or PBS-treated groups that had survived to 7 d (un-
published data). These findings indicated that in this murine
model, the key mechanisms linked to survival and regenera-
tion was operative within the first 7 d after massive resection.
These data led us to consider if inherent differences in
RAGE expression in the liver accounted for the ability of
the relatively few PBS-treated animals to survive massive re-
section. Thus, we tested levels of RAGE transcripts in the
resected tissue (85% of the liver) to determine if RAGE ex-
pression differed in this tissue retrieved from mice that sur-
vived or succumbed (at 7 d). We found that there were no
significant differences in RAGE mRNA transcripts in the
resected tissue of mice that survived or died by 7 d, irrespec-
tive of sRAGE or PBS treatment in the 85% resection group
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20040934/DC1). These findings suggest that basal dif-
ferences in RAGE expression in the liver did not account for
the likelihood of survival or death after 85% resection.
Indices of liver necrosis (release of alanine transferase),
function (prothrombin time), and restoration of liver mass
(% liver weight/body weight), were significantly improved
in mice treated with sRAGE, 100 
 
 
 
g per day, versus vehi-
cle, PBS (Fig. 2, B–D). The differences in survival between
sRAGE-treated mice and those receiving vehicle were
greatest early after hepatectomy. Inevitably, only innately re-
sistant survivors populated the vehicle-treated group beyond
40 h. Therefore, survival in the relatively fewer vehicle- ver-
sus sRAGE-treated mice both converged toward full resto-
ration of mass and liver function over time.
We examined the remnants from vehicle- and sRAGE-
treated mice to determine the impact of massive hepatec-
tomy on the remnant and the potential influence of RAGE
blockade. Sections were prepared from liver remnants and
stained with hematoxylin and eosin. Frank necrosis was visi-
ble in centrilobular regions (graded 0–3; reference 12). De-
struction of the liver parenchyma, in the form of necrosis,
was observed in mice treated with PBS at 24 h (Fig. 2, E and
F). However, preservation of liver parenchyma with an ab-
sence of necrosis was observed in the remnant tissue of mice
treated with sRAGE (Fig. 2, E and F).
Consistent with the premise that administration of
sRAGE trapped proinflammatory ligands of RAGE, im-
munoprecipitation of plasma retrieved from mice receiving
Figure 3. Blockade of RAGE modulates expression of inflammatory 
and regenerative mediators after massive hepatectomy. 8 h after 
sham surgery, 70 or 85% resection in the presence of vehicle or sRAGE 
treatment, hepatic remnants were retrieved and subjected to quantitative 
PCR for detection of transcripts for the following: A, TNF- ; B, IL-6; C, IL-10; 
D, VCAM-1; and E, IFN- . After normalization to internal controls, fold 
changes relative to sham surgery remnant transcript levels (“1.0”) were 
reported. n   5 mice per condition. *, P   0.05 versus sham control. 
**, P   0.05 versus PBS treatment. 
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sRAGE, but not PBS, with anti-RAGE IgG revealed S100/
calgranulin antigen by blotting (Fig. 2 G). In contrast, im-
munoprecipitation of sRAGE-treated plasma with nonim-
mune rabbit IgG failed to reveal bands immunoreactive with
S100/calgranulin (unpublished data).
 
Blockade of RAGE and cytokine generation after 
massive hepatectomy
 
To explore the mechanisms underlying diminished regener-
ation associated with massive hepatectomy and the protec-
tive effects of sRAGE, we assessed levels of proinflammatory
mediators linked to these processes. We examined transcripts
for TNF-
 
 
 
, a multifactorial cytokine that displays pleiotropic
effects; in partial (70%) hepatectomy, TNF-
 
 
 
 promotes re-
generation and suppresses apoptosis; however, in a highly in-
flamed milieu, TNF-
 
 
 
 has been linked to tissue injury (13–
15). At 8 h after massive hepatectomy, TNF-
 
 
 
 transcripts by
quantitative PCR were significantly increased in the hepatic
remnant in sRAGE-treated mice versus those receiving PBS;
P 
 
  
 
0.05. In addition, levels of TNF-
 
 
 
 transcripts in PBS-
treated remnants were not different than those observed in
sham-treated livers (Fig. 3 A). Examination of transcripts en-
coding TNF-
 
 
 
 in remnants retrieved from mice undergoing
70% resection revealed significantly lower levels compared
with sRAGE-treated mice undergoing 85% resection; P 
 
 
 
0.05 (Fig. 3 A). These findings underscore the concept that
distinct mechanisms are recruited upon 85% versus less ex-
tensive 70% resection.
Next, we examined levels of IL-6, as this cytokine, regu-
lated largely by TNF-
 
 
 
, has been importantly linked to regen-
erative processes after liver injury (16–18). Previous studies
demonstrated that infusion of IL-6 in mice subjected to partial
hepatectomy in genetically modified mice resistant to TNF-
 
 
 
secondary to deletion of type 1 TNF-
 
 
 
 receptor restored re-
generation (14). Analogous to the pattern of expression of
TNF-
 
 
 
 after massive hepatectomy, IL-6 transcripts in the he-
patic remnant were significantly higher in sRAGE-treated
mice versus PBS at 8 h; P 
 
  
 
0.05, and versus PBS-treated mice
undergoing 70% resection; P 
 
  
 
0.05 (Fig. 3 B). These findings
underscore the premise that both TNF-  and IL-6 expression
are associated with regeneration, particularly after massive
hepatectomy, and that RAGE blunts expression of these pro-
tective mediators after largely lethal resection of the liver.
The remnants of sRAGE-treated mice also displayed sig-
nificantly increased transcripts for an antiinflammatory cyto-
kine IL-10 (19) at 8 h after resection compared with PBS-
treated mice; P   0.05 (Fig. 3 C). Levels of vascular cell
adhesion molecule-1 (VCAM-1) transcripts were not signifi-
cantly different at 8 h in sRAGE- versus PBS-treated mice
after massive hepatectomy. Although levels of IFN-  tran-
scripts were significantly higher in remnants after 85% resec-
tion versus sham surgery (P   0.05), there was no significant
impact of sRAGE treatment in 85% resection. Together,
these findings suggest that VCAM-1 and IFN-  likely did
not critically contribute to failure of regeneration after mas-
sive resection (Fig. 3, D and E).
Blockade of RAGE and modulation of NF- B activation after 
massive liver resection
To determine the impact of massive resection on key path-
ways regulating transcription and cell fate in the remnant, we
examined activation of NF- B, a pleiotropic transcription
factor that mediates proinflammatory pathways and prolifer-
ative/antiapoptotic programs in developing and injured liver
(20–22). Multiple studies report that NF- B is significantly
activated by 70% hepatectomy (23). At 2 h after massive
hepatectomy (85%), nuclear translocation of NF- B in the
PBS-treated hepatic remnants was not significantly increased
compared with 70% partial hepatectomy (Fig. 4 A). How-
ever, in the presence of sRAGE/85% hepatectomy, an ap-
proximately fivefold increase in activation of NF- B was
noted compared with vehicle treatment or 70% hepatectomy
at 2 h; P   0.05 (Fig. 4 A). Supershift assays revealed that the
NF- B complex after massive hepatectomy consisted of
both p50 and p65 antigens, but especially p50, as demon-
strated by incubation of the nuclear extract with anti-p50
and/or anti-p65 IgG (Fig. 4 B). In competition studies, addi-
tion of a 10-fold excess of unlabeled NF- B probe resulted
in disappearance of the band.
Immunohistochemistry using an antibody selective for
activated NF- B (p65) showed strong nuclear positivity
within clusters of hepatocytes most prominently in a perivas-
cular distribution around central and portal venules at 2 h af-
ter massive resection in sRAGE-treated mice (Fig. 4 C). Ap-
preciable NF- B immunoreactivity was not detectable in
the hepatic remnants after massive resection in the PBS-
treated group at 2 h.
In contrast, by 8 h after massive hepatectomy, nuclear
translocation of NF- B was only marginally increased in the
PBS-treated group versus 70% hepatectomy,  1.7-fold (Fig.
4 A). Electrophoretic mobility shift assays (EMSAs) revealed
that in sRAGE-treated remnants at 8 h, levels of activated
NF- B were not different than those observed in 70% resec-
tion, but were significantly less than levels seen in PBS-
treated remnants after 85% resection; P   0.05 (Fig. 4 A).
Immunohistochemistry revealed that at 8 h after massive re-
section in PBS-treated mice, nuclear staining for NF- B did
not localize to hepatocytes; rather, it scattered nonparenchy-
mal liver cells, such as Kupffer cells, endothelial cells, and oc-
casional inflammatory cells, largely expressing the activated
form of this transcription factor (Fig. 4 C).
Blockade of RAGE enhances proliferation and reduces 
apoptosis in hepatocytes after massive hepatectomy
Next, we addressed the potential consequences of activated
NF- B, particularly in the sRAGE-treated remnants. At 24 h
after massive hepatectomy, sRAGE-treated remnants dis-
played increased immunoreactivity for proliferating cell nu-
clear antigen (PCNA) in hepatocytes; P   0.05 (Fig. 4 D).
Consistent with increased proliferation in the sRAGE-
treated remnant, levels of cyclin D1 antigen (24), a target
gene of NF- B (25), were higher in sRAGE- versus PBS-
treated remnants by Western blotting; P   0.05 (Fig. 4 E).RAGE REGULATES LIVER REGENERATION | Cataldegirmen et al. 478
Figure 4. Blockade of RAGE modulates activation of NF- B after 
massive hepatectomy. (A) EMSA. Nuclear extracts were prepared from 
the remnants of the indicated mice and the EMSA was performed. The illus-
trated bands are representative of n   4–6 mice per condition. **, P   0.05 JEM VOL. 201, February 7, 2005 479
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TUNEL  cells were markedly reduced in sRAGE- versus
PBS-treated remnants at 16 h after massive resection (Fig. 4
F), in parallel with decreased activated caspase-3 antigen at 8
and 16 h; P   0.05 (Fig. 4 G).
Furthermore, although a central role has been ascribed to
hepatocyte growth factor-1 in hepatocyte replication and re-
generation (26, 27), serial analysis after massive hepatectomy
revealed approximately 5-, 10- and 4-fold higher antigen
levels of hepatocyte growth factor-1 in hepatic remnants re-
trieved from PBS- versus sRAGE-treated mice at 8, 16, and
24 h, respectively (unpublished data). Thus, in massive re-
section, despite up-regulation of this factor, regenerative
programs appear to be ineffective.
RAGE-expressing cells of MP lineage mediate failure of 
regeneration after massive liver resection
Cellular localization studies suggested that CD68 /CD11c 
MPDDCs were the principal RAGE-expressing cells in the
liver remnant after massive hepatectomy. To ascribe a role
for RAGE in cells of MP lineage to the tissue-injurious
pathways activated upon massive hepatectomy, we used
transgenic mice bearing selective introduction of cytosolic
tail–deleted human RAGE into MP lineage cells, driven by
the type A scavenger receptor promoter (SR; references 28,
29). Introduction of cytosolic tail–deleted RAGE into en-
dogenously RAGE-bearing cells causes a “dominant nega-
tive” (DN) effect both in vitro and in vivo upon ligand en-
gagement (30–32). Tissue localization studies indicated that
RAGE was expressed to enhanced degrees in cells expressing
CD68 and CD11c, suggesting that DN RAGE was ex-
pressed in both Kupffer cells and MPDDCs in these trans-
genic mice (Fig. 5, A–D).
To determine the impact of introduction of DN RAGE
in cells of MP lineage in massive hepatectomy, we assessed
survival. Kaplan-Meier product-limit estimates revealed that
upon massive hepatectomy, transgenic SR DN-RAGE mice
displayed significantly increased survival compared with wild-
type littermates ( 90% vs. 20%, respectively; P   0.004; Fig.
5 E). At 8 h, TNF-  and IL-6 transcripts were significantly
increased in the remnants of transgenic SR DN-RAGE mice
compared with littermate controls; P   0.05 (Fig. 5, F and
G). EMSAs performed on nuclear extracts from transgenic
SR DN RAGE mouse remnants at 2 h after massive hepatec-
tomy revealed a significant increase in activated NF- B ver-
sus wild-type littermates subjected to the same degree of
injury; P   0.05 (Fig. 5 H). Addition of excess unlabeled
NF- B probe resulted in disappearance of the band (Fig. 5
H). In contrast, at 8 h, although no differences were observed
in activation of NF- B in transgenic SR DN RAGE mice
versus littermates after 70% hepatectomy, a significant attenu-
ation of NF- B activation was noted in transgenic SR DN
RAGE versus littermate mice at 8 h; P   0.05 (Fig. 5 H). Su-
pershift studies confirmed that the NF- B complex in both
sets of mice consisted of both p50 and p65 (unpublished
data). Levels of cyclin D1 antigen in the hepatic remnants of
transgenic SR DN RAGE mice were increased  7.5- and
 5-fold higher at 8 and 36 h compared with littermate con-
trols, respectively; P   0.05 (Fig. 5 I). By 7 d after massive
hepatectomy, liver/body weight ratios were fully restored in
the transgenic mice (unpublished data).
DISCUSSION
In homeostasis, the portal vein continually bathes the liver
with toxic products released from microorganisms or deliv-
ered from the intestinal tract. In addition, a wide array of an-
tigens is continually delivered to and processed by the liver,
without evoking untoward inflammatory or immune re-
sponses. Even upon removal of 70% of the liver, the small
remnant facilitates regeneration-provoking programs to re-
store mass and function. A key element of liver regeneration
in 70% hepatectomy is up-regulation of hepatocyte NF- B,
beginning as early as 30 min after resection and peaking at
1–2 h (23), in parallel with enhanced expression of regenera-
tion-promoting cytokines TNF-  and IL-6.
Our findings provide experimental evidence that sup-
ports the clinical observation that the regenerative capacity
of the liver is finite. These data demonstrate for the first time
that RAGE-dependent mechanisms contribute to remnant
hepatocyte necrosis/apoptosis and failure of proliferation af-
ter massive liver resection. In contrast, in sRAGE-treated
mice or transgenic mice in which RAGE signaling in cells of
MP lineage is disrupted, the remnants displayed significant
up-regulation of NF- B, particularly in hepatocytes, beyond
that observed in 70% resection or vehicle-treated 85% hepa-
tectomy. In parallel, increased transcripts for TNF-  and IL-6
were observed. The failure to observe significant activation
of hepatocyte NF- B after 85% hepatectomy in vehicle-
treated animals at 2 h suggests that RAGE prevents its acti-
vation, thereby leading to preferential activation of pro-
apoptotic mechanisms and suppression of proliferation. In
sRAGE-treated remnants, early activation of NF- B, within
the first 2 h, is likely critically linked to the transcriptional
versus PBS treatment/85% resection. (B) Supershift assay. Remnants re-
trieved from mice undergoing 85% hepatectomy in the presence of sRAGE 
at 2 h were retrieved and subjected to incubation with anti-p50, anti-p65, 
or both anti-p50 and anti-p65 IgG before EMSA. (C) Immunohistochemistry. 
Hepatic remnants at 2 and 8 h were retrieved and subjected to immuno-
histochemistry with anti-p65 NF- B subunit antibodies. Bar, 50  m. 
(D) Proliferation. Hepatic remnants were retrieved and subjected to immu-
nohistochemistry with anti-PCNA IgG and mean numbers of PCNA  cells 
were determined from n   10 fields per section/mouse. The indicated re-
sults are representative of n   5 mice per condition. Bars, 80  m. (inset) 
160  m. (E) Western blotting of hepatic remnant lysates was performed at 
the indicated times using anti-cyclin D1 IgG. The illustrated bands are rep-
resentative of n   3–4 mice per condition. (F) Apoptosis. Hepatic remnants 
were retrieved and subjected to TUNEL assay and mean numbers of TUNEL  
cells determined from n   10 fields per section/mouse. The indicated results 
are representative of n   5 mice per condition. Bar, 40  m. (G) Western 
blotting on remnants was performed using anti-activated caspase-3 IgG. 
The illustrated bands are representative of n   5 mice per condition. In all 
cases, bands were scanned into a densitometer and relative pixel units of 
band density reported. *, P   0.05 versus PBS/85% resection.RAGE REGULATES LIVER REGENERATION | Cataldegirmen et al. 480
Figure 5. Transgenic mice expressing DN RAGE in cells of MP lin-
eage display enhanced survival and liver regeneration after massive 
hepatectomy. Transgenic mice expressing human DN RAGE selectively in 
cells of MP lineage using the scavenger receptor type A promoter were 
used for these studies. (A–D) Immunofluorescence microscopy. Immunofluo-
rescence for detection of RAGE antigen was performed in sections pre-
pared from the remnants of transgenic mice 8 h after sham surgery (A) or 
massive resection (B, 85%). Double immunofluorescence staining was per-
formed on sections prepared from transgenic mice 8 h after massive re-
section using the following antibodies: anti-RAGE IgG (C and D, green) 
and anti-CD68 IgG (C, red) or anti-CD11c IgG (D, red). Single and merged 
images are shown. (A and B) Bars, 100  m; (C and D) Bars, 50  m. 
(E) Kaplan-Meier Product Limit Estimate. The times of death were recorded 
for transgenic versus littermate control mice undergoing massive hepatec-
tomy and survival was plotted. (F and G) Quantitative PCR. Massive hepa-
tectomy was performed in transgenic (DN) and wild-type littermate mice JEM VOL. 201, February 7, 2005 481
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up-regulation of one of its key targets, the cell cycle regula-
tory molecule, cyclin D1 (24, 25, 33). In parallel, the prore-
generative effects of TNF-  are directly linked to its ability
to facilitate the priming phase (G0–G1) of the cell cycle (34).
These experiments provide yet an additional contrast with
the biology of partial (70%) hepatectomy, as it has recently
been shown that blockade of hepatocyte NF- B causes
apoptosis after injection of TNF, but not after partial hepa-
tectomy (35). In 85% resection, suppressed activation of
NF- B was associated with increased apoptosis. Because
the principal RAGE-expressing cells in the remnants were
CD68 /CD11c  inflammatory cells, these findings suggest
that the products of activated inflammatory cells in the rem-
nant generate an environment in which rapid up-regulation
of hepatocyte NF- B is subsequently thwarted.
What are the RAGE-expressing cells that mediate injury
consequent to massive hepatectomy? An intriguing finding
in our studies is that the hepatocytes themselves do not ex-
press appreciable RAGE epitopes, either in the basal state or
after massive resection. Rather, MPDDCs are the principal
RAGE-expressing cells in the remnant after massive resec-
tion (36, 37). In contrast, Kupffer cells, distributed widely
throughout the liver, did not express RAGE in the basal or
perturbed state. Although our studies using sRAGE or anti-
RAGE F(ab )2 fragments do not indicate the specific cellular
target, experiments using transgenic mice expressing signal-
ing-deficient mutant RAGE in cells of MP lineage provide
direct insights into the role of RAGE signaling in the target
cells of this promoter.
Based on the use of the type A SR to drive expression of
DN RAGE, at least three distinct classes of cells may express
DN RAGE in the transgenic mice. Although Kupffer cells
prominently expressed the DN RAGE transgene, we posit
that their impact in RAGE-modulated injury after massive
hepatectomy is not a key determining factor linking massive
resection to failure of regeneration. Little to no Kupffer cell
RAGE expression was noted in the remnant in wild-type
mice after massive resection; yet, pharmacological blockade
of RAGE in wild-type animals significantly modulated sur-
vival and regeneration. The presence of RAGE staining lo-
calized largely to CD11c /CD68  cells (thus, MPDDCs,
not Kupffer cells) in wild-type mice suggests that MPDDCs
are the principal RAGE-expressing cells in the remnant. In
the transgenic mice, as well, DN RAGE was expressed in
MPDDCs under the control of this promoter. It is important
to note that peripheral blood–derived monocytes may also
express the DN RAGE transgene, and that these cells might
contribute to RAGE-mediated injury after massive resec-
tion. Although our pathologic analysis did not demonstrate
detectable inflammatory infiltrates at early or late times
within the remnant after massive resection, it is not possible
to fully exclude the potential impact of low numbers of infil-
trating peripheral blood–derived MP after massive resection
on the response to injury in the present studies.
In this context, novel roles for MPDDCs in multiple fac-
ets of the immune/inflammatory response in the liver are
emerging (36, 37). Indeed, studies suggest that MPDDCs are
an heterogeneous population of cells, whose distinct func-
tions may range from antigen recognition and processing to
generation of cytokines with varied effects on the adaptive
immune response, such as IL-12, IFN- , TNF- , and IL-6
(38). Discrete subsets have been identified; each of which
likely plays distinct roles in diverse settings, from allogeneic
transplantation to infection. Furthermore, these cells display
migratory properties, and may traverse the liver into periph-
eral lymphoid compartments; processes potentially linked to
induction of tolerance (38).
Our studies point to deleterious functions of MPDDCs,
at least in part via RAGE, in massive resection. Future stud-
ies must address two central questions; first, what is the im-
pact of massive resection on MPDDCs properties and, sec-
ond, what classes of MPDDCs express RAGE in both the
unperturbed state and postmassive resection? Importantly,
our findings by quantitative PCR revealed that transcripts
for IFN-  were increased in PBS-treated mice after massive
resection, but that treatment with sRAGE did not signifi-
cantly attenuate levels of this cytokine. However, levels of
IL-10 transcripts were significantly higher in sRAGE-treated
remnants. These data suggest that proinflammatory effects of
MPDDCs, at least those expressing RAGE, may dominate
the remnant upon massive resection, as treatment with
sRAGE enhanced expression of a key antiinflammatory cy-
tokine, IL-10. Indeed, studies in an autoimmune model of
type 1 diabetes in NOD mice revealed that blockade of
RAGE attenuated the time to development of hyperglyce-
mia in NOD/SCID mice injected with diabetogenic spleno-
cytes from diabetic NOD animals (39). In parallel with
decreased islet expression of proinflammatory cytokines, in-
creased islet expression of antiinflammatory cytokines such as
IL-10 and TGF-  was shown (39). These studies, together
with the present work, suggest that RAGE activates proin-
flammatory pathways that, either directly or indirectly, at-
tenuate the expression and biologic impact of antiinflamma-
tory mediators. In these present studies, potential roles for
subsets of MPDDCs expressing RAGE in pro- versus antiin-
flammatory mechanisms must be dissected. Such concepts
form the basis of ongoing investigation.
Together, these findings highlight novel insights into
pathogenic roles for RAGE, at least in part in MPDDCs, in
inhibition of regeneration after massive liver resection. We
(WT). Hepatic remnants were retrieved at 8 h after resection and subjected 
to quantitative PCR for detection of transcripts for TNF-  (F) and IL-6 (G). 
After normalization to internal controls, fold changes relative to WT mice 
remnant transcript levels (“1.0”) are reported. n   5 mice per condition. 
*, P   0.05 versus WT mice. (H) EMSA. Massive hepatectomy was performed 
in transgenic (DN) and wild-type littermate mice (WT). Remnants were re-
trieved at 2 and 8 h, and nuclear extracts were prepared for EMSA. Bands 
were scanned into a densitometer and relative pixel units of band density 
reported. *, P   0.05 versus WT mice/85% resection. (I) Western blotting. 
At the indicated times after massive resection, hepatic remnants were re-
trieved and subjected to Western blotting using anti-cyclin D1 IgG. (H and 
I) The illustrated bands are representative of n   3–4 mice per condition.RAGE REGULATES LIVER REGENERATION | Cataldegirmen et al. 482
propose that RAGE antagonism may provide a new modal-
ity to expand the limits of tolerable resection and, thus, lead
to novel strategies to salvage livers and hosts overwhelmed
by massive hepatic insult.
MATERIALS AND METHODS
Animals and surgical procedures. Male C57BL/6 mice (The Jackson
Laboratory), weighing 25–28 g, were used in all experiments and main-
tained in a temperature-controlled room with alternating 12-h light/dark
cycles. All experiments were approved by the Institutional Animal Care and
Use Committee of Columbia University.
In n   18 mice, each lobe was weighed and compared with the total
weight of the liver; results are reported in the percent of total liver weight.
The lobes of the liver reflect the following percentage/total weight: middle
and left lobes,  65.5   2.6%; right superior lobe,  13.7   1.7%; right in-
ferior lobe,  13.8   1.9%; and the lobus caudatus,  6.8   1.8%. In the
first model,  65.5   2.6% of the liver was resected by removing the left
and middle lobes of the liver; the caudate and right lobes remained intact. In
the second model,  85% of the liver was resected. In addition to the left
and middle lobes of the liver, the caudate and right inferior lobes of the liver
were removed. Approximately 86.2   2.1% of the liver was resected; the
hepatic remnant was composed of the right superior lobe. Animals were ex-
amined every 6 h for the duration of the study to estimate time of death.
Certain mice were treated with murine sRAGE (11) or vehicle, PBS. Mice
were treated once daily by intraperitoneal administration beginning 1 d be-
fore surgery, and once daily until they were killed at the indicated time
points. In other experiments, F(ab )2 fragments of rabbit nonimmune, anti-
RAGE, anti-S100/calgranulin, or antiamphoterin IgG were prepared ac-
cording to the manufacturer’s instructions using a kit from Pierce Chemical
Co. The indicated F(ab )2 fragments were administered to the mice 12 h
before the surgery and once daily until they were killed.
Analyses of plasma and serum. Mice were killed and blood was with-
drawn through cardiac puncture. Plasma was assayed for prothrombin time
and serum was assayed for levels of bilirubin, albumin, and alanine ami-
notransferase by Ani Lytics, Inc. Levels of blood glucose were assayed using
a glucometer, Accu Chek Advantage (Boehringer).
Immunohistochemistry and histology. Consecutive sections (5  m)
from paraffin-embedded liver were prepared for hematoxylin-eosin stain-
ing, TUNEL, and PCNA immunohistochemistry. Sections of liver remnant
were subjected to hematoxylin and eosin staining and the degree of necrosis
was graded based on the percentage of cells involved, similar to a grading
system used for the determination of hepatic steatosis (12) as follows: grade
0, no necrosis; grade 1, necrosis of  30% of (centrilobular) hepatocytes;
grade 2, necrosis of 30–60% (centrilobular) hepatocytes; and grade 3,  60%
(centrilobular) hepatocytes. The TUNEL  cells were identified using an
apoptosis kit from Intergen. Staining for detection of PCNA was performed
using mouse anti-PCNA IgG (DakoCytomation) as described previously
(40). To detect activated NF- B, formalin-fixed sections were prepared and
subjected to immunostaining with a rabbit polyclonal antibody against NF-
 B, p65 subunit (1:50 dilution; Santa Cruz Biotechnology, Inc.) as de-
scribed previously (40).
Immunofluorescence. To detect RAGE epitopes, and to localize RAGE
antigen to distinct cell types, single and double immunofluorescence stain-
ing was performed in frozen sections as described previously (40). In brief,
after blocking with normal serum, sections were incubated with rabbit anti-
RAGE IgG (1:50 dilution; reference 40) and incubated with a biotinylated
goat anti–rabbit IgG (1:100; Vector Laboratories) followed by incubation
with streptavidin-conjugated to Alexa Fluor 555 green (1  g/ml; Molecular
Probes, Inc.). After blocking with avidin/biotin solution (Vector Laborato-
ries), the same sections were incubated with rat anti–mouse CD68 IgG
(1:50 dilution; Serotec) and incubated with a biotinylated rabbit anti–rat
IgG (1:100; Vector Laboratories) followed by streptavidin conjugated to Al-
exa Fluor 555 red (1  g/ml; Molecular Probes, Inc.). In other double stain-
ing procedures, hamster anti–mouse CD11c (1:25 dilution; BD Biosciences)
was used as another primary antibody and incubated with a secondary bio-
tinylated goat anti–hamster IgG (1:100; BD Biosciences) and Alexa Fluor
555 red. The slides were photographed using fluorescence microscopy.
Immunoprecipitation and Western blotting. Plasma was retrieved
from sRAGE- and PBS-treated mice 16 h after massive hepatectomy. 300
 l of plasma was diluted with buffer A (1% NP-40; 100 mM Tris, pH 8.0;
20% glycerol; 0.2 mM EDTA; 400 mM NaCl; 200  M Na3VO4; 100 mM
NaF; 2 mM DTT; and 0.8 mM PMSF). Nonspecific binding to rabbit IgG
was performed by a preclearing step; the diluted plasma was incubated with
2  g of rabbit IgG (Sigma-Aldrich) and protein A agarose beads for 1 h at
4 C. Samples were centrifuged, and the supernatants were further incubated
with 3  g/ml rabbit anti–human RAGE IgG or 3  g/ml nonimmune rab-
bit IgG and protein A agarose beads for 2 h at 4 C. The supernatants were
discarded, and beads were resuspended in nonreducing sample buffer and
subjected to SDS-PAGE. The gels were transferred to nitrocellulose and
blotted using rabbit anti-S100/calgranulin IgG (Sigma-Aldrich).
The whole protein was extracted from frozen liver tissues using lysis
buffer (10 mM Tris HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton
X-100, 10% Glycerol, 2 mM sodium orthovanadate, and complete protease
inhibitor cocktail; Roche Diagnostics). Western blotting was performed as
described previously (40).
EMSAs. Nuclear proteins were prepared from the liver tissues using the
isolation kit from Pierce Chemical Co. NF- B DNA binding activity
was measured using end-labeled double-stranded NF- B oligonucleotide
(Promega) as described previously (40). Supershift analysis was performed
by incubating nuclear extracts with 0.5  g of antibodies against p50 or p65
subunit of NF- B (Santa Cruz Biotechnology, Inc.) before adding the
 -[32P] ATP-labeled oligonucleotide (40).
Quantification of gene expression using real-time PCR. Total RNA
was isolated using TRIzol reagent (Life Technologies) and was processed
directly to cDNA synthesis using the TaqMan Reverse Transcription Re-
agents Kit (Applied Biosystems). Primers and TaqMan probes were designed
by Primer Express 2.0 software (Applied Biosystems), except for GAPDH,
which was commercially available. The primers and probes were as follows:
mouse RAGE forward primer, 5 -GGACCCTTAGCTGGCACTTAGA-
3 , reverse primer, 5 -GAGTCCCGTCTCA-GGGTGTCT-3 , and probe,
6FAM-ATTCCCGATGGCAA-AGAAACACTCGTG-TAMRA. Mouse
TNF-  forward primer, 5 -AATGGCCTCCCTCTCAT-CAGT-3 , re-
verse primer, 5 -GCTACAGGCTTGTCACTCGAATT-3 , and probe,
6FAM-ATGGCCCAGACCCTCACA-CTCAGATC-TAMRA.  Mouse
IL-6 forward primer, 5 -TATGAAGTTCCTCTCTGCAAGAGA-3 , re-
verse primer, 5 -TAGGGAAGGCCGTGGTT-3 , and probe, 6FAM-CCA-
GCATCAGTCCCAAGAAGGCAACT-TAMRA. VCAM-1 forward primer,
5 -CTGAATACAAAACGATCGCTCAA-3 , reverse primer, 5 -GCGTT-
TAGTGGGC-TGTCTATCTG-3 , and probe, 6FAM-CGGTGACTC-
CATGGCCCTCACTTG-TAMRA. IL-10 and IFN-  probe and primers
were purchased from Applied Biosystems. Quantitative real-time PCR was
performed using the ABI Prism 7900 Sequence Detection System (Applied
Biosystems). Data are calculated by 2-  Ct method as described by the man-
ufacturer and are expressed as the fold increases over the indicated controls
(“1.0”) in each figure.
Transgenic SR-DN RAGE mice. Transgenic SR DN RAGE mice
were prepared using the type A SR provided to us by C. Glass (University of
California, San Diego, La Jolla, CA; reference 28). The generation and char-
acterization of these mice has been described previously (29). Mice were gen-
erated and hemizygous mice, from two different founders, were backcrossed
eight generations into C57BL/6 before study. Littermates not expressing the
transgene were used as controls in these studies.JEM VOL. 201, February 7, 2005 483
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Statistical analysis. All data are reported as mean   SD. Data were ana-
lyzed by analysis of variance and, as indicated, subject to post hoc compari-
sons using two-tailed Student’s t test. For survival studies, the Kaplan-Meier
method was used to analyze survival. The log-rank test was used to compare
survival curves. Differences were considered significant when P   0.05.
Online supplemental material.  To determine if RAGE expression dif-
fered in the resected tissue retrieved from mice that survived or succumbed
after 70% or 85% hepatectomy by 7 d, real-time PCR for detection of
RAGE transcript was performed for Fig. S1. Similarly, the resected tissues at
the time of surgery or remnants from mice that survived by 14 d were sub-
jected to PCR for detection of TNF-  transcript. Liver weight/body
weight was measured. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20040934/DC1.
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